Kylin Therapeutics' Grant

Kylin Therapeutics raised a round of funding on January 23, 2009. Investors include Elevate Ventures.

Kylin Therapeutics, a biotechnology company, employs a RNA nanoparticle technology platform called"pRNA" to exploit the potential of RNA interference (RNAi) for treatment of many common diseases inc…

Articles about Kylin Therapeutics' Grant: